UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Biomedical chromatography, ISSN 0269-3879, 03/2017, Volume 31, Issue 3, pp. np - n/a
metformin | saxagliptin | ion‐pair solid phase extraction | LC–MS/MS | human plasma | 5‐hydroxy saxagliptin | 5-hydroxy saxagliptin | ion-pair solid phase extraction | Reproducibility of Results | Adamantane - blood | Humans | Solid Phase Extraction | Chromatography, Liquid - methods | Tandem Mass Spectrometry - methods | Dipeptides - blood | Metformin - blood | Adamantane - analogs & derivatives | Surface active agents | Metabolites | Ionization | Analysis | Nitriles | Liquid chromatography | Hypoglycemic agents | Dosage and administration | Sulfates | Mass spectrometry | Index Medicus
Journal Article
Clinical pharmacokinetics, ISSN 0312-5963, 2012, Volume 51, Issue 8, pp. 501 - 514
Journal Article
Journal of hypertension, ISSN 0263-6352, 10/2018, Volume 36 Suppl 3, pp. e64 - e64
Journal Article
Process biochemistry (1991), ISSN 1359-5113, 02/2018, Volume 65, p. 109
Journal Article
Current medical research and opinion, ISSN 0300-7995, 04/2012, Volume 28, Issue 4, pp. 513 - 523
Dipeptidyl peptidase-4 inhibitor - DPP-4 - Hypoglycemia - Insulin - Saxagliptin - Type 2 diabetes | Dipeptidyl peptidase-4 inhibitor DPP-4 Hypoglycemia Insulin Saxagliptin Type 2 diabetes | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptides - adverse effects | Humans | Middle Aged | Insulin - administration & dosage | Male | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Metformin - adverse effects | Dipeptides - administration & dosage | Drug Therapy, Combination - methods | Hypoglycemic Agents - administration & dosage | Adolescent | Adult | Female | Aged | Metformin - administration & dosage | Adamantane - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Adamantane - adverse effects | Adamantane - analogs & derivatives | Index Medicus
Journal Article
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, ISSN 1386-1425, 11/2020, Volume 241, p. 118638
ANN | Sitagliptin | GA | Vildagliptin | PLS | Saxagliptin | Spectroscopy | Technology | Science & Technology
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2018, Volume 321, Issue 1, pp. 69 - 79
KIDNEY-DISEASE | MORTALITY | GFR DECLINE | END-POINT | SAXAGLIPTIN | HEART-FAILURE | SITAGLIPTIN | DEATH | OUTCOMES | CKD | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Kidney Failure, Chronic - mortality | Cardiovascular Diseases - etiology | Double-Blind Method | Cardiovascular Diseases - prevention & control | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Risk Factors | Linagliptin - adverse effects | Proportional Hazards Models | Male | Linagliptin - therapeutic use | Glycated Hemoglobin A | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Therapy, Combination | Hypoglycemia - chemically induced | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Kidney Failure, Chronic - etiology | Type 2 diabetes | Usage | Clinical trials | Research | Risk factors | Complications and side effects | Analysis | Placebos | Linagliptin | Dosage and administration | Kidney diseases | Cardiovascular diseases | Drug therapy | Myocardial infarction | End-stage renal disease | Adjudication | Risk | Effects | Incidence | Vascular diseases | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Urine | Creatinine | Cerebral infarction | Stroke | Kidneys | Peptidase | Epidermal growth factor receptors | Diabetes mellitus | Pancreatitis | Health risks | Hypoglycemia | Insulin | Patients | Placebo effect | Prescription drugs | Renal failure | Infarction | Adults | Diabetes | Index Medicus | Abridged Index Medicus | Online First | Original Investigation
Journal Article
European journal of pharmacology, ISSN 0014-2999, 05/2019, Volume 851, p. 186
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Biochemical and biophysical research communications, ISSN 0006-291X, 09/2018, Volume 503, Issue 3, p. 1618
Journal Article
Microchemical journal, ISSN 0026-265X, 05/2020, Volume 154, p. 104560
Journal Article
Diabetes care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 376 - 383
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Benzhydryl Compounds - administration & dosage | Humans | Middle Aged | Male | Metformin - adverse effects | Benzhydryl Compounds - adverse effects | Urinary Tract Infections - chemically induced | Adult | Female | Metformin - administration & dosage | Adamantane - administration & dosage | Drug Therapy, Combination | Hypoglycemia - chemically induced | Glucosides - adverse effects | Adamantane - adverse effects | Adamantane - analogs & derivatives | Double-Blind Method | Dipeptides - adverse effects | Treatment Outcome | Blood Glucose - drug effects | Dipeptides - administration & dosage | Diabetes Mellitus, Type 2 - blood | Glucosides - administration & dosage | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Care and treatment | Usage | Analysis | Clinical trials | Dosage and administration | Glycemic index | Metformin | Saxagliptin | Drug therapy | Diabetes | Index Medicus
Journal Article
ACS catalysis, ISSN 2155-5435, 03/2019, Volume 9, Issue 3, pp. 2292 - 2302
Journal Article
Diabetes care, ISSN 0149-5992, 01/2017, Volume 40, Issue 1, pp. 69 - 76
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Albuminuria - etiology | Double-Blind Method | Diabetic Nephropathies - etiology | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Serum Albumin - analysis | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Dipeptides - administration & dosage | Glomerular Filtration Rate - drug effects | Albuminuria - drug therapy | Creatinine - blood | Female | Aged | Adamantane - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Diabetes Mellitus, Type 2 - complications | Adamantane - analogs & derivatives | Type 2 diabetes | Complications and side effects |